AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the technology.

AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the Centers ...

The purpose of this study was to evaluate whether the 12-lead ECG could be substituted by ECG sets with a limited number of leads. Materials and methods: The performance of three ECG systems (ie ...

When looking at a 12-lead ECG, a few logistics must be understood. First, the standard 12-lead ECG is a 10-second strip. The bottom one or two lines will be a full “rhythm strip” of a specific ...

Kardia 12L performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities. "AliveCor's Kardia 12L ECG System was born from our vision to leverage AI and ...

Therefore, the criteria for diagnosing LAE on a 12-lead ECG is as follows: The length of the P wave in lead II is greater than 120 milliseconds OR The downward deflection of the P wave in lead V1 ...

It was tested in a prospective, single-blind study of 200 heart patients against the standard traditional 12-lead EKG procedure. Errors that impacted the interpretability of the EKG were detected ...

Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for ...

The results indicated that Kardia 12L ECG System (with its reduced leadset) performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities, including bundle ...